Procurement of Normal and Diseased Esophageal Tissue Specimens for Preliminary Studies Evaluating Dysregulated Th2 Immune Responses

Overview

About this study

The purpose of this study is to systematically analyze the function of various immune cells in the esophagus, we need to perform a series of preliminary pilot studies on sections of esophageal biopsy specimens to optimize experimental conditions, examine the feasibility of several new cell biologic and immunologic techniques, and obtain preliminary data to estimate statistical parameters (e.g. individual variability and standard deviation).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Chart review to identify patients who underwent endoscopy whose biopsies were diagnosed with esophageal disease
Patients who underwent endoscopy but whose biopsies were read out as histologically normal.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Hirohito Kita, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Hirohito Kita, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials